(Q77535845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

meta-analysis

0 references

title

Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

1 reference

S C Reimold

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

W H Maisel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

E M Antman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

8A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

66N-71N

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

The Combination of Estimates from Different Experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Intravenous propafenone for termination of reentrant supraventricular tachycardia. A placebo-controlled, randomized, double-blind, crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Feasibility of out-of-hospital treatment of supraventricular tachycardias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Restoration of sinus rhythm in atrial fibrillation of recent onset using intravenous propafenone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Clinical course of recent-onset atrial fibrillation treated with oral propafenone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Usefulness of propafenone for recurrent paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Therapeutic efficacy and safety of oral propafenone for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Treatment of Supraventricular Tachycardia Due to Atrioventricular Nodal Reentry by Radiofrequency Catheter Ablation of Slow-Pathway Conduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900587-6

10.1016/S0002-9149(98)00587-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809903%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference